Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management - Aug 2, 2021

Abbott announced today that the U.S. Food and Drug Administration (FDA) has cleared the FreeStyle® Libre 2 iOS application for use with compatible iPhones1, providing a comprehensive digital

FS Libre 2 on the App Store

Download the FreeStyle Libre 2 App & LibreLink App

Diabetes Products, Abbot Freestyle Libre 2 CGM

Health Canada-approved iOS app helps diabetic patients monitor glucose

Abbott's FreeStyle Libre 2 iOS App Cleared in U.S., Providing a Seamles's Digital Experience to Simplify Diabetes Management

Download the FreeStyle Libre 2 App & LibreLink App

Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management - Aug 2, 2021

Abbott FreeStyle Libre 2 iOS App Receives FDA Approval - JDRF

424B4

What Is Continuous Glucose Monitoring? (CGM)

Frequently Asked Questions

Abbott FreeStyle Libre 2

DRC & Research News Archives Diabetes Research Connection

Download the FreeStyle Libre 2 App & LibreLink App